VEA and VGK rank among the more popular choices for investors seeking equity exposure outside the United States. They are not interchangeable, however. VGK functions essentially as a regional subset of the wider universe covered by VEA. The former delivers a core allocation to developed markets ex-U.S., while the latter isolates developed European equities. Deciding between them comes down to questions of breadth versus focus, diversification versus concentration, and overall cost efficiency.
VEA is a passively managed ETF designed to track the FTSE Developed All Cap ex US Index. This market-capitalization-weighted benchmark includes large-, mid-, and small-cap stocks from developed markets outside the United States. The fund maintains approximately 3,900 holdings, placing it among the broadest options in the international developed-equity space. Japan, the United Kingdom, and Canada represent the largest country weights, with Europe accounting for roughly half of assets and the Pacific region about one-third. Top holdings remain modest in size, with names such as Samsung Electronics, SK Hynix, ASML Holding, HSBC Holdings, Roche Holding, Royal Bank of Canada, Novartis, AstraZeneca, Nestlé, and Shell each staying below roughly 2.5% of assets. Financials lead the sector allocation at approximately 24%, followed by industrials and technology. The expense ratio stands at 0.03%. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers on cost and holdings metrics.
VGK tracks the FTSE Developed Europe All Cap Index and holds roughly 1,230 securities across large-, mid-, and small-cap European companies. The United Kingdom, Switzerland, France, and Germany form the largest country exposures, followed by the Netherlands, Spain, Sweden, and Italy. Concentration is higher here, with ASML Holding comprising about 4.4% of assets. Other notable positions include HSBC Holdings, Roche Holding, Novartis, Nestlé, Shell, Siemens, AstraZeneca, SAP, and Banco Santander. Financials again lead at around 25%, with industrials near 19% and healthcare near 12%. The expense ratio is 0.06%.
Both ETFs sit within the developed international equity category, where recent cycles have reflected easing monetary policy expectations alongside still-elevated interest rates that have supported bank profitability. Artificial intelligence and semiconductor demand have benefited technology holdings, including Asia-based names in VEA and ASML in both funds. Europe-specific factors such as defense spending, energy transition investment, and pharmaceutical innovation also play a role, while Japan’s corporate governance reforms add a distinct element captured only by VEA. Risks include regional slowdowns, currency movements, and geopolitical developments.
Both funds have participated in the recent recovery in developed international equities, though their drivers differ. VEA has benefited from exposure to Japanese and Korean semiconductor leaders as well as Canadian holdings. VGK has drawn more from European banks, pharmaceuticals, and capital goods, with ASML as its largest single influence. VEA’s wider holdings base generally supports lower idiosyncratic risk, whereas VGK’s narrower mandate increases sensitivity to European-specific developments. Investors seeking a diversified core allocation have often leaned toward VEA, while those preferring a deliberate Europe overweight may favor VGK.
When comparing funds like these, I find it helpful to run additional screens for technical patterns, fundamentals, and volatility metrics. Tickeron’s AI Screener lets me apply customizable filters across thousands of ETFs and stocks to highlight differences in holdings concentration, sector weights, and performance characteristics that might otherwise take considerable manual effort to surface.
Based on structural characteristics, the AI-assisted view favors VEA over VGK at present. VEA combines a lower expense ratio, far broader diversification across nearly 3,900 holdings, and multi-region exposure that captures semiconductor and financials momentum across Asia and Europe while limiting single-stock and single-country risk. VGK remains suitable for a targeted Europe allocation, yet its higher concentration and narrower scope bring greater sensitivity to regional outcomes. On a risk-adjusted and cost-adjusted basis, VEA’s breadth and efficiency currently appear the more durable choice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for VEA turned positive on October 27, 2026. Looking at past instances where VEA's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 58 cases where VEA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VEA as a result. In 69 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for VEA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeBlend